To access this element change to forms mode OFF
Grant Award View - GA288991
Intracerebral delivery of Neuropeptide Y through hiPSC-derived...
GA ID:
GA288991
Agency:
Department of Health and Aged Care
Approval Date:
9-Dec-2022
Publish Date:
20-Mar-2023
Category:
Medical Research
Grant Term:
1-Feb-2023 to 31-Jan-2025
Value (AUD):
$671,512.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 22/23 1.1 Health Policy Research and Analysis
Grant Program:
Medical Research Future Fund
Grant Activity:
Intracerebral delivery of Neuropeptide Y through hiPSC-derived progenitors (NPY-hiPSC- NPs ) as a disease-modifying treatment for drug-resistant epilepsy
Purpose:
Epilepsy is a serious brain condition and seizure cannot be controlled despite the best available treatments in ~30% patients. The underlying mechanisms of drug resistance are poorly understood. We aim to investigate whether stem cells can be used as vehicles to deliver Neuropeptide Y, that can suppress seizures in drug-resistant epilepsy. This study will provide novel insights into how epilepsy develops, and form the basis for the development of novel disease modifying treatment strategies.
GO ID:
GO Title:
MRFF – Stem Cell Therapies Mission – 2022 Stem Cell Therapies Grant Opportunity
Internal Reference ID:
2022/MRF2024363
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
Monash University
Recipient ABN:
12 377 614 012
Grant Recipient Location
Suburb:
Clayton
Town/City:
Clayton
Postcode:
3800
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
Country:
AUSTRALIA